Tumor volume is a valid surrogate endpoint for defining clinically significant prostate cancers

Jonas Hugosson, Hans Lilja, Pär Lodding, Carl Gustav Pihl

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)33-34
JournalEuropean Urology
Volume39
Issue numberSuppl 4
DOIs
Publication statusPublished - 2001

Subject classification (UKÄ)

  • Clinical Medicine

Cite this